Breast cancer is the most frequently diagnosed cancer among women1

Incidence, mortality, and survival for metastatic breast cancer

INDICATION

ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

Breast cancer is the most frequently diagnosed cancer among women1

mbc-epidemiology-mobile-chart
aTotal metastatic incidence includes newly diagnosed and newly recurrent.
mbc-mortality-survival-mobile

Characteristics, such as the presence of visceral metastases and the number of metastatic wp-content, are associated with aggressive disease4,5

INDICATION

ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

INDICATION

ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.